Effect of estrogen on the metabolism of metyrapone and release of ACTH.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000236:Adenoma; D000310:Adrenal Gland Neoplasms; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008656:Mestranol / Q000494:pharmacology* / Q000627:therapeutic use; D008797:Metyrapone / Q000378:metabolism*
D015065:17-Hydroxycorticosteroids; D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D006854:Hydrocortisone; D008797:Metyrapone